Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial by Masi, Gianluca, Dr, Loupakis, Fotios, MD, Salvatore, Lisa, MD, Fornaro, Lorenzo, MD, Cremolini, Chiara, MD, Cupini, Samanta, MD, Ciarlo, Andrea, MD, Del Monte, Francesca, PhD, Cortesi, Enrico, MD, Amoroso, Domenico, MD, Granetto, Cristina, MD, Fontanini, Gabriella, Prof, Sensi, Elisa, MD, Lupi, Cristiana, MD, Andreuccetti, Michele, CTA, Falcone, Alfredo, MD

Get full text